Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2021 | 2 |
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
HER2 chimeric antigen receptor T cell immunotherapy is an effective treatment for diffuse intrinsic pontine glioma.
Neurooncol Adv. 2023 May 4;5(1):vdad024. doi: 10.1093/noajnl/vdad024. eCollection 2023 Jan-Dec.
Neurooncol Adv. 2023.
PMID: 37152812
Free PMC article.
To go or not to go? Biological logic gating engineered T cells.
Abbott RC, Hughes-Parry HE, Jenkins MR.
Abbott RC, et al. Among authors: hughes parry he.
J Immunother Cancer. 2022 Apr;10(4):e004185. doi: 10.1136/jitc-2021-004185.
J Immunother Cancer. 2022.
PMID: 35379738
Free PMC article.
Review.
Item in Clipboard
The Evolving Protein Engineering in the Design of Chimeric Antigen Receptor T Cells.
Hughes-Parry HE, Cross RS, Jenkins MR.
Hughes-Parry HE, et al.
Int J Mol Sci. 2019 Dec 27;21(1):204. doi: 10.3390/ijms21010204.
Int J Mol Sci. 2019.
PMID: 31892219
Free PMC article.
Review.
Item in Clipboard
Human EGFRvIII chimeric antigen receptor T cells demonstrate favorable safety profile and curative responses in orthotopic glioblastoma.
Abbott RC, Iliopoulos M, Watson KA, Arcucci V, Go M, Hughes-Parry HE, Smith P, Call MJ, Cross RS, Jenkins MR.
Abbott RC, et al. Among authors: hughes parry he.
Clin Transl Immunology. 2023 Mar 5;12(3):e1440. doi: 10.1002/cti2.1440. eCollection 2023.
Clin Transl Immunology. 2023.
PMID: 36890859
Free PMC article.
Item in Clipboard
Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells effectively eliminate human glioblastoma.
Abbott RC, Verdon DJ, Gracey FM, Hughes-Parry HE, Iliopoulos M, Watson KA, Mulazzani M, Luong K, D'Arcy C, Sullivan LC, Kiefel BR, Cross RS, Jenkins MR.
Abbott RC, et al. Among authors: hughes parry he.
Clin Transl Immunology. 2021 May 9;10(5):e1283. doi: 10.1002/cti2.1283. eCollection 2021.
Clin Transl Immunology. 2021.
PMID: 33976881
Free PMC article.
Item in Clipboard
Erratum: Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells effectively eliminate human glioblastoma.
Abbott RC, Verdon DJ, Gracey FM, Hughes-Parry HE, Iliopoulos M, Watson KA, Mulazzani M, Luong K, D'Arcy C, Sullivan LC, Kiefel BR, Cross RS, Jenkins MR.
Abbott RC, et al. Among authors: hughes parry he.
Clin Transl Immunology. 2021 Jul 18;10(7):e1317. doi: 10.1002/cti2.1317. eCollection 2021.
Clin Transl Immunology. 2021.
PMID: 34295472
Free PMC article.
Item in Clipboard
Cite
Cite